News Agency
Men's Weekly

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

  • Written by PR Newswire
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

MELBOURNE, Australia and SAN FRANCISCO, Oct. 27, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States.

BioMUSE is a natural history study that aims to track the progression of...

Read more: Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

Your Post-Study Work Visa Could Do More Than You Think — If You Use It Right

Completing your education in Australia is a great milestone, but every international graduate has to face the infamous: what's next? For some, the Temporary Graduate Visa (subclass 485) appears to be the next logical step as it allows you to... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion